Zahra Arab Sadeghabadi

Zahra Arab Sadeghabadi

Auto-generated profile, based on publicly available information

Zahra Arab Sadeghabadi

Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in Discover Nano
Verified
Journal Article
Open access
PDF file
RMRoohollah Mohseni
Roohollah Mohseni
ZAZahra ArabSadeghabadi
Zahra ArabSadeghabadi
NZNasrin Ziamajidi
Nasrin Ziamajidi
RARoghayeh Abbasalipourkabir
Roghayeh Abbasalipourkabir
ARAzam RezaeiFarimani
Azam RezaeiFarimani
In the current study, we developed resveratrol (RES)-loaded solid lipid nanoparticle (SLN-RES) in order to improve insulin resistance through the upregulation of SNARE protein complex in rats with type 2 diabetes. The SLN-RES characteristics include the following: the average size of 248 nm, the zeta potential of − 16.5 mV, and 79.9% RES entrapment efficiency. The release profile of SLN-RES showed an initial burst followed by a sustained release in natural condition. Infrared spectroscopy results revealed good incorporation of RES into core SLN. Spherical nanoparticle with less aggregation was observed under electronic microscopic examination. Oral administration of SLN-RES prevented weight loss and showed better hypoglycemic effect than RES. Serum oxidative stress status was restored to the normal level by SLN-RES. Furthermore, expression of synaptosomal-associated protein 23 (Snap23), syntaxin-4 (Stx4), and vesicle-associated membrane protein 2 (Vamp2) as the major elements of SNARE protein complex were reduced by SLN-RES more significantly than RES treatment in muscle tissue. However, SLN-RES has a similar effect to RES treatment in adipose tissue. Taken together, our results revealed SLN-RES could be a modern and interestingly therapeutic approach for the improvement of insulin resistance through targeting the expression of Snap23, Stx4, and Vamp2 in adipose and muscle tissues.

5 December 2022 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
RMRoohollah Mohseni
Roohollah Mohseni
MTMaryam Teimouri
Maryam Teimouri
MSMohsen Safaei
Mohsen Safaei
ZSZahra Arab Sadeghabadi
Zahra Arab Sadeghabadi


1 January 2021 in International Journal of Hypertension
Verified
Journal Article
Open access
PDF file
ZSZahra Arab Sadeghabadi
Zahra Arab Sadeghabadi
MNMitra Nourbakhsh
Mitra Nourbakhsh
MAMohammad Alaee
Mohammad Alaee
MNMona Nourbakhsh
Mona Nourbakhsh
SGSeyedeh Sara Ghorbanhosseini
Seyedeh Sara Ghorbanhosseini
MRMaryam Razzaghy-Azar
Maryam Razzaghy-Azar
Background . Angiopoietin‐like protein 2 (ANGPTL2) is one of the adipocyte‐derived inflammatory factors which connects obesity to insulin resistance. ANGPTL3 has a direct role in regulation of lipid metabolism. The objective of this study was to evaluate ANGPTL2 and ANGPTL3 in childhood obesity and their relationship with metabolic syndrome. Methods . 70 children and adolescents, 35 obese and 35 normal‐weight subjects, were enrolled in this research after complete clinical examination and anthropometric evaluations. Serum ANGPTL2 and ANGPTL3 and insulin were measured by enzyme‐linked immunosorbent assay (ELISA). Homeostatic model assessment of insulin resistance (HOMA‐IR) was calculated and used to estimate insulin resistance (IR). Colorimetric methods were used for the assessment of fasting plasma glucose (FPG), LDL‐C, HDL‐C, total cholesterol (TC), and triglyceride (TG). Results . The levels of ANGPTL2 and ANGPTL3 were significantly higher in obese subjects than those in controls, but they did not differ significantly in subjects with or without IR. ANGPTL3 was found to be significantly elevated in obese children with metabolic syndrome (MetS) in comparison with those without MetS. Both of the studied ANGPTLs were positively correlated with BMI, systolic blood pressure (SBP), diastolic blood pressure (DBP), TC, and LDL‐C. The correlation between ANGPTL3 and either TC or LDL‐C remained significant after adjusting for BMI. Conclusion . Serum ANGPTL2 and ANGPTL3 were elevated in obesity and associated with blood pressure and indices of metabolic syndrome, suggesting that they might be involved in the advancement of obesity‐related hypertension and metabolic syndrome.

20 April 2026 in Journal of Shahrekord University of Medical Sciences
Verified
Journal Article
Closed access
ZSZahra Arab Sadeghabadi
Zahra Arab Sadeghabadi
ASAmeneh Zamani Sedehi
Ameneh Zamani Sedehi
KSKeihan Ghatreh Samani
Keihan Ghatreh Samani
AMAli Momeni
Ali Momeni
RMRoohollah Mohseni
Roohollah Mohseni
Background and aims: The Toll-like receptor-4 (TLR-4) signaling pathway and its interaction with cytokines are involved in insulin resistance (IR) progression, primarily through activating adipose tissue macrophages. Interleukin-29 (IL-29) has been suggested as a potential contributor to IR. Therefore, this study aimed to assess the relationship between TLR-4 and IL-29 expression alterations in the peripheral blood mononuclear cells of newly diagnosed type 2 diabetes (T2D) patients. Methods: Overall, 60 participants were enrolled, comprising equal numbers of newly diagnosed T2D patients and healthy controls. Quantitative real-time polymerase chain reaction was employed to determine the messenger RNA expression levels of toll-like receptor-4 (TLR-4), interleukin (IL)-29, TIR-domain-containing adapter-inducing interferon-β (TRIF), and interferon regulatory factor 3 (IRF3). Moreover, serum IL-29 concentrations were quantified using an enzyme-linked immunosorbent assay. Data were analyzed through SPSS 16. In addition, an independent-sample t-test was used to compare the data between the two groups. Ultimately, the relationship between variables was assessed using Pearson’s correlation coefficient. Results: Overall, IL-29 serum levels were significantly increased in the T2D group compared to the control group (P<0.001). Additionally, the gene expression levels of IL-29, TLR4, TRIF, and IRF3 were markedly upregulated in T2D patients relative to healthy individuals (P<0.001). Conclusion: These findings revealed that IL-29 overexpression is linked to the activation of the TLR-4 pathway, which may contribute to the pathogenesis of IR in T2D.